Akoya Biosciences Dirección
Dirección controles de criterios 3/4
El CEO de Akoya Biosciences es Brian McKelligon , nombrado en Jul 2017, tiene una permanencia de 7.33 años. compensación anual total es $2.92M, compuesta por 18.6% salario y 81.4% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.075% de las acciones de la empresa, por valor de $80.42K. La antigüedad media del equipo directivo y de la junta directiva es de 3.1 años y 4.3 años, respectivamente.
Información clave
Brian McKelligon
Chief Executive Officer (CEO)
US$2.9m
Compensación total
| Porcentaje del salario del CEO | 18.6% |
| Permanencia del CEO | 7.3yrs |
| Participación del CEO | 0.08% |
| Permanencia media de la dirección | 3.1yrs |
| Promedio de permanencia en la Junta Directiva | 4.3yrs |
Actualizaciones recientes de la dirección
Recent updates
Revenue Downgrade: Here's What Analysts Forecast For Akoya Biosciences, Inc. (NASDAQ:AKYA)
Nov 19
Is Akoya Biosciences (NASDAQ:AKYA) Using Too Much Debt?
Nov 12Akoya Biosciences, Inc. (NASDAQ:AKYA) Stock Rockets 36% But Many Are Still Ignoring The Company
Oct 08Akoya Biosciences, Inc. (NASDAQ:AKYA) Just Reported, And Analysts Assigned A US$5.42 Price Target
Aug 09Market Might Still Lack Some Conviction On Akoya Biosciences, Inc. (NASDAQ:AKYA) Even After 31% Share Price Boost
Jun 27Is Akoya Biosciences (NASDAQ:AKYA) A Risky Investment?
Jun 24We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Akoya Biosciences, Inc.'s (NASDAQ:AKYA) CEO For Now
May 29Investors Continue Waiting On Sidelines For Akoya Biosciences, Inc. (NASDAQ:AKYA)
May 10Is Akoya Biosciences (NASDAQ:AKYA) Weighed On By Its Debt Load?
Feb 28Investors Still Aren't Entirely Convinced By Akoya Biosciences, Inc.'s (NASDAQ:AKYA) Revenues Despite 31% Price Jump
Nov 25Akoya Biosciences Seeks Growth Despite Higher Operating Losses
May 30Akoya Biosciences, Inc. (NASDAQ:AKYA) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
May 11Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$58m |
| Jun 30 2024 | n/a | n/a | -US$60m |
| Mar 31 2024 | n/a | n/a | -US$68m |
| Dec 31 2023 | US$3m | US$543k | -US$63m |
| Sep 30 2023 | n/a | n/a | -US$71m |
| Jun 30 2023 | n/a | n/a | -US$76m |
| Mar 31 2023 | n/a | n/a | -US$73m |
| Dec 31 2022 | US$3m | US$518k | -US$71m |
| Sep 30 2022 | n/a | n/a | -US$69m |
| Jun 30 2022 | n/a | n/a | -US$63m |
| Mar 31 2022 | n/a | n/a | -US$51m |
| Dec 31 2021 | US$2m | US$393k | -US$44m |
| Sep 30 2021 | n/a | n/a | -US$34m |
| Jun 30 2021 | n/a | n/a | -US$28m |
| Mar 31 2021 | n/a | n/a | -US$28m |
| Dec 31 2020 | US$516k | US$350k | -US$22m |
| Dec 31 2019 | US$484k | US$333k | -US$18m |
Compensación vs. Mercado: La compensación total de Brian($USD2.92M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD652.28K).
Compensación vs. Ingresos: La compensación de Brian ha sido consistente con los resultados de la empresa en el último año.
CEO
Brian McKelligon (55 yo)
7.3yrs
Permanencia
US$2,919,599
Compensación
Mr. Brian McKelligon has been Chief Executive Officer and Director at Akoya Biosciences, Inc. since July 2017 and also serves as its President. Prior to joining Akoya, he led corporate and business develop...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| President | 7.3yrs | US$2.92m | 0.075% $ 80.4k | |
| CFO, Principal Financial Officer & Principal Accounting Officer | 1.7yrs | US$2.37m | 0.092% $ 98.8k | |
| Senior Director of Business Development & Investor Relations Strategy | no data | sin datos | sin datos | |
| General Counsel | 1.8yrs | sin datos | 0.012% $ 13.2k | |
| Chief Business Officer | 4.3yrs | US$365.22k | 0.29% $ 312.8k | |
| Senior Vice President | 3.1yrs | sin datos | 0.17% $ 178.8k | |
| Secretary | no data | sin datos | sin datos |
3.1yrs
Permanencia media
51yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de AKYA se considera experimentado (3.1 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| President | 7.3yrs | US$2.92m | 0.075% $ 80.4k | |
| Independent Director | 9yrs | US$251.66k | 0.75% $ 798.3k | |
| Independent Director | 3.2yrs | US$237.50k | 0.040% $ 43.2k | |
| Independent Director | 5.2yrs | US$220.00k | 0% $ 0 | |
| Director | 9yrs | US$210.00k | 0.47% $ 506.7k | |
| Independent Director | 7.3yrs | US$232.50k | 1.99% $ 2.1m | |
| Member of Scientific Advisory Board | less than a year | sin datos | sin datos | |
| Independent Chairman | 3.4yrs | US$250.00k | 0.058% $ 61.6k | |
| Member of Scientific Advisory Board | less than a year | sin datos | sin datos | |
| Chair of the Scientific Advisory Board | less than a year | US$220.00k | 1.24% $ 1.3m |
4.3yrs
Permanencia media
66yo
Promedio de edad
Junta con experiencia: La junta directiva de AKYA se considera experimentada (4.3 años de antigüedad promedio).